Cargando…
Pseudothrombocytopenia by ethylenediaminetetraacetic acid can jeopardize patient safety – report
Pseudothrombocytopenia by ethylenediaminetetraacetic acid (EDTA) is an infrequent phenomenon of in vitro platelet agglutination due to the presence of antiplatelet autoantibodies. It has no clinical significance, but misdiagnosis may lead to clinical or therapeutic decision-making. In this study we...
Autores principales: | Abal, Cristina Collazo, Calviño, Leticia Rodríguez, Manso, Laura Rollán, Domínguez, M. C. Ferreirós, Lorenzo, M.J. Lorenzo, Balboa, Cristina Regojo, Fernández Nogueira, Arturo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109506/ https://www.ncbi.nlm.nih.gov/pubmed/32256290 |
Ejemplares similares
-
Surgical Delay due to Ethylenediaminetetraacetic Acid-Induced Pseudothrombocytopenia
por: Kharel, Himal, et al.
Publicado: (2020) -
Ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia, presenting as spurious pancytopenia, associated with risperidone
por: Mamtani, Harkishan, et al.
Publicado: (2023) -
Poorer Prognosis With Ethylenediaminetetraacetic Acid-dependent Pseudothrombocytopenia: A Single-center Case–control Study
por: Ohashi-Fukuda, Naoko, et al.
Publicado: (2015) -
Can Pseudothrombocytopenia be recognised at first look?
por: Yilmaz, Seda, et al.
Publicado: (2023) -
Rejection of hemolyzed samples can jeopardize patient safety
por: Barbato, Lorenzo, et al.
Publicado: (2020)